Concepedia
Statistics
Publications
16
Citations
775
H-Index
Active since
2006
Affiliations
Erasmus MC(Current)
Albert Schweitzer Ziekenhuis
Erasmus MC Cancer Institute
Erasmus University Rotterdam
Reinier de Graaf Hospital
Jos Kitzen is an author at Erasmus MC specializing in medicine, oncology, and pharmacology.
Publications per year
2006–2022
Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial
Vivianne C. G. Tjan‐Heijnen, Irene E.G. van Hellemond, Petronella G.M. Peer et al. · The Lancet Oncology · 2017 · 158 citations
Medicine, Endocrinology, Pharmacology +14
Phase I dose-escalation study of F60008, a novel apoptosis inducer, in patients with advanced solid tumours
Jos Kitzen, Maja J.A. de Jonge, C. B. H. W. Lamers et al. · European Journal of Cancer · 2009 · 90 citations
Life Sciences, Oncology, Pharmacology +14
Effectiveness of a Hospital-Based Work Support Intervention for Female Cancer Patients – A Multi-Centre Randomised Controlled Trial
Sietske J. Tamminga, Jos Verbeek, Monique M.E.M. Bos et al. · PLoS ONE · 2013 · 88 citations · Full text
Nursing, Oncology, Cancer Survivorship Care +16
Medicinal Cannabis Does Not Influence the Clinical Pharmacokinetics of Irinotecan and Docetaxel
Frederike K. Engels, Floris A. de Jong, Alex Sparreboom et al. · The Oncologist · 2007 · 74 citations · Full text
Medicine, Pharmacokinetics, Pharmacology +16
A phase Ib study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumours
Gerhardt Attard, Jos Kitzen, Sarah P. Blagden et al. · British Journal of Cancer · 2007 · 71 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 16